Tel-Aviv and Paris, January 6th, 2008 - Cukierman & Co. Life Sciences (a leading Israeli provider of corporate finance and business development services to the life science industry) and Aurgalys (a French company specializing in strategic, managerial and operational support for biotech and healthcare businesses) have joined forces in order to offer their European, North American and Israeli customers comprehensive services that are better suited to today’s business and market environments.
“This alliance underlines our commitment to the life science industry in general and biotech in particular and will enable us to meet the needs of our clients across the world (and notably in France) even more effectively”, emphasized Philippe Berthon, General Partner at Aurgalys. Aurgalys differentiates itself from its competitors by offering an entrepreneurial, custom approach to life science markets: “We are entrepreneurs serving entrepreneurs: our approach is founded on commitment, experience, responsiveness and adaptability”, commented Philippe Berthon.
“Despite the current bottlenecks in traditional financial channels, at least for the first quarter of 2009, and in order to meet the financing and strategic development needs of our clients, we offer corporate finance solutions with a special focus on M&A and strategic partnering and we are now systematically broadening our funding searches globally”, added Serge Goldner, Managing Partner of Cukierman & Co. Life Sciences. Aurgalys and Cukierman & Co. Life Sciences’ joint offering for client companies now covers corporate finance, business development, interim management, and management consultancy. For investors, the offering includes due diligence, interim management and investment assistance.
About Cukierman & Co. Life Sciences
Founded in 1993, Cukierman & Co. Investment House Ltd is the leading European oriented investment house, headquartered in Israel. Since its establishment, Cukierman & Co. has been engaged in transactions valued at €2.36B through Private Placements, Initial Public Offerings and Mergers and Acquisitions. In addition, Cukierman & Co. has developed a dominant position in Private Equity through the Catalyst Fund.
Cukierman & Co. Life Sciences (CLS) was established in 2006 as the Life Sciences Corporate Finance arm of Cukierman & Co. Investment House Ltd. Dr. Laurent Choppe, Cukierman & Co. Life Sciences managing partner, is leading Cukierman & Co. Life Sciences’ European office in Switzerland. For more information, visit: www.cukierman.co.il
About Aurgalys
Aurgalys provides specialist, custom support for biotech and healthcare businesses and investors and notably provides assistance to clients seeking finance, development and R&D strategies, collaborations and other business relationships. The company was founded in 2007 by Philippe Berthon, PhD, a renowned expert in life science, a field in which he has created and managed several biotech companies. Aurgalys’ clients include pharma, diagnostics, bioresearch, medtech and biopharma companies. For more information on Aurgalys, visit: www.aurgalys.com
